Cancer drug development has never moved faster. Yet, for too many patients, the next treatment decision still begins with ...

Intravacc offers state-of-the-art analytical methods for identity, content, purity, structure, formulation, stability, and preclinical ...

In my previous article, I discussed how AI is rapidly transforming the drug discovery process, significantly accelerating timelines and reducing costs. However, while AI's potential in this domain is ...

Generative AI based on Large Language Models (LLMs), the technology behind popular tools like ChatGPT and Google Gemini, is revolutionizing various industries, including the world of drug discovery.

Reasons for Hope Compared to a decade ago, there are substantially more drugs (a 35% increase) being tested for Alzheimer’s ...

The U.S. Food and Drug Administration (FDA) announced on Wednesday (October 29) a plan to streamline the approval process for biosimilars, which are generic versions of complex biological drugs. These ...

In 2022, the combined research and development (R&D) expenditure of the U.S. pharmaceutical industry consisted of more than $100 billion. While this is a significantly expansive market, approximately ...

A post hoc analysis of a study investigating drugs containing semaglutide, such as Ozempic and Wegovy, in those living with ...

Glucagon-like peptide-1 (GLP-1) receptor agonist medications have gained widespread attention for effectively treating ...

The US Food and Drug Administration will take steps to streamline the development of generic versions of complex biological drugs, the agency announced Wednesday. The changes are meant to accelerate ...